FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $21,267,000 | -59.1% | 619,855 | -73.5% | 1.57% | -71.1% |
| Q1 2020 | $52,013,000 | +488.8% | 2,341,875 | +418.9% | 5.43% | +582.7% |
| Q4 2019 | $8,833,000 | -1.4% | 451,354 | -80.1% | 0.80% | -33.3% |
| Q3 2017 | $8,960,000 | +9.0% | 2,262,678 | -10.8% | 1.19% | -18.2% |
| Q2 2017 | $8,220,000 | -28.8% | 2,537,026 | 0.0% | 1.46% | -50.0% |
| Q1 2017 | $11,543,000 | +526.7% | 2,537,026 | +329.6% | 2.92% | +416.5% |
| Q3 2016 | $1,842,000 | – | 590,527 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |